» Articles » PMID: 3566249

Effect of Broad-spectrum Parenteral Antibiotics on Composition of Intestinal Microflora of Humans

Overview
Specialty Pharmacology
Date 1987 Feb 1
PMID 3566249
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

We compared the effects of four beta-lactam drugs with widely differing antibacterial and pharmacological properties on the composition of the intestinal flora. Cefoxitin, piperacillin, cefoperazone, and aztreonam were given intravenously for 9 days to healthy volunteers. Cefoperazone reduced the numbers of aerobic and anaerobic bacteria to undetectable levels. At the other extreme, cefoxitin had little effect on the normal flora. Aztreonam markedly reduced the numbers of aerobes, whereas piperacillin had a variable effect on both aerobic and anaerobic bacteria. There was extensive overgrowth of enterococci in subjects given cefoxitin or aztreonam, which have little activity against this species, and of yeasts in subjects given cefoperazone or piperacillin. Cefoperazone reached concentrations of 2,727 to 8,840 micrograms/g in the feces, whereas the other agents were generally undetectable. These results show that the new beta-lactam antibiotics produce widely varying effects on the fecal microflora after parenteral administration and that these effects are consistent with the antibacterial and pharmacological properties of the drugs.

Citing Articles

Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups.

Zhang C, Zhong B, Jiang Q, Lu W, Wu H, Xing Y BMC Med. 2025; 23(1):148.

PMID: 40059138 PMC: 11892250. DOI: 10.1186/s12916-025-03982-7.


Incidence of Invasive Infections Among Hemato-Oncology Patients with Significant Burden of Candida in Stool.

Edri R, Cohen M, Dror D, Korem M Mycopathologia. 2023; 188(4):371-381.

PMID: 37294507 DOI: 10.1007/s11046-023-00758-6.


Interactions between and the resident microbiota.

Li H, Miao M, Jia C, Cao Y, Yan T, Jiang Y Front Microbiol. 2022; 13:930495.

PMID: 36204612 PMC: 9531752. DOI: 10.3389/fmicb.2022.930495.


Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.

Cao D, Liu W, Lyu N, Li B, Song W, Yang Y Microbiol Spectr. 2021; 9(3):e0061521.

PMID: 34908436 PMC: 8672887. DOI: 10.1128/spectrum.00615-21.


In Vitro Properties of Potential Probiotic Indigenous Yeasts Originating from Fermented Food and Beverages in Taiwan.

Hsiung R, Fang W, LePage B, Hsu S, Hsu C, Chou J Probiotics Antimicrob Proteins. 2020; 13(1):113-124.

PMID: 32472389 DOI: 10.1007/s12602-020-09661-8.


References
1.
Abrams G, Bishop J . Effect of the normal microbial flora on the resistance of the small intestine to infection. J Bacteriol. 1966; 92(6):1604-8. PMC: 316237. DOI: 10.1128/jb.92.6.1604-1608.1966. View

2.
Welling G, Groen G, Tuinte J, Koopman J, Kennis H . Biochemical effects on germ-free mice of association with several strains of anaerobic bacteria. J Gen Microbiol. 1980; 117(1):57-63. DOI: 10.1099/00221287-117-1-57. View

3.
Van Der Waaij D, Berghuis J, Lekkerkerk J . Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J Hyg (Lond). 1972; 70(4):605-10. PMC: 2130274. DOI: 10.1017/s0022172400022464. View

4.
Freter R, Abrams G . Function of various intestinal bacteria in converting germfree mice to the normal state. Infect Immun. 1972; 6(2):119-26. PMC: 422503. DOI: 10.1128/iai.6.2.119-126.1972. View

5.
Swabb E, Singhvi S, Leitz M, FRANTZ M, Sugerman A . Metabolism and pharmacokinetics of aztreonam in healthy subjects. Antimicrob Agents Chemother. 1983; 24(3):394-400. PMC: 185331. DOI: 10.1128/AAC.24.3.394. View